BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Choden T, Mandaliya R, Charabaty A, Mattar MC. Monitoring inflammatory bowel disease during pregnancy: Current literature and future challenges. World J Gastrointest Pharmacol Ther 2018; 9(1): 1-7 [PMID: 29430322 DOI: 10.4292/wjgpt.v9.i1.1]
URL: https://www.wjgnet.com/1007-9327/full/v9/i1/1.htm
Number Citing Articles
1
Nahla A. Azzam, Abdulelah Almutairdi, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Bawardy, Mahmoud H. Mosli. Saudi consensus guidance for the management of inflammatory bowel disease during pregnancySaudi Journal of Gastroenterology 2023;  doi: 10.4103/sjg.sjg_318_23
2
L. L. H. Peeters, P. W. de Leeuw, E. D. Post Uiterweer. Pathophysiology of pregnancy complications2021; : 175 doi: 10.1007/978-90-368-2571-9_4
3
Michael Udegbune, Hayley Sharrod–Cole, Sarah Townsend, Ben Allen, Matthew J Brookes, Clare Ford, Rousseau Gama. Diagnostic performance of serum calprotectin in discriminating active from inactive ulcerative colitis in an outpatient settingAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine 2022; 59(6): 404 doi: 10.1177/00045632221116830
4
Amihai Rottenstreich, Tali Mishael, Sorina Grisaru Granovsky, Benjamin Koslowsky, Hagai Schweistein, Guila Abitbol, Eran Goldin, Ariella Bar-Gil Shitrit. Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseasesEuropean Journal of Internal Medicine 2020; 77: 105 doi: 10.1016/j.ejim.2020.03.015
5
Amihai Rottenstreich, Maayan Diminsky, Sorina Grisaru Granovsky, Tali Mishael, Batia Roth, Galia Spectre, Yosef Kalish, Eran Goldin, Ariella Bar-Gil Shitrit. Assessment of the procoagulant potential and associated risk factors in pregnant patients with inflammatory bowel diseasesEuropean Journal of Internal Medicine 2019; 65: 63 doi: 10.1016/j.ejim.2019.04.013
6
James M. Gray, Kristin Knight, Vu Q. Nguyen, Marrieth G. Rubio, Lauren Irby, James H. Boone, Dario Sorrentino. Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the LiteratureInflammatory Intestinal Diseases 2020; 5(3): 151 doi: 10.1159/000508970
7
Nariman Hossein-Javaheri, Michael Youssef, Yaanu Jeyakumar, Vivian Huang, Parul Tandon. The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative ReviewReproductive Medicine 2023; 4(3): 180 doi: 10.3390/reprodmed4030017
8
Günther A. Rezniczek, Claudia Förster, Ziad Hilal, Timm Westhoff, Clemens B. Tempfer. Calprotectin in pregnancy and pregnancy-associated diseases: a systematic review and prospective cohort studyArchives of Gynecology and Obstetrics 2019; 299(6): 1567 doi: 10.1007/s00404-019-05134-8
9
Richard Y. Wu, Parul Tandon, Lindsy Ambrosio, Garett Dunsmore, Naomi Hotte, Levinus A. Dieleman, Shokrollah Elahi, Karen Madsen, Vivian Huang. Post-neonatal Outcomes of Infants Born to Women with Active Trimester One Inflammatory Bowel Disease: A Pilot StudyDigestive Diseases and Sciences 2022; 67(11): 5177 doi: 10.1007/s10620-022-07430-x
10
Reem Al-jabri, Panu Wetwittayakhlang, Peter L. Lakatos. Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different ModalitiesJournal of Clinical Medicine 2023; 12(23): 7343 doi: 10.3390/jcm12237343
11
Laura C. Sahyoun, Jill K. J. Gaidos. A Practical Approach to IBD Care in the Pregnant PatientCurrent Gastroenterology Reports 2022; 24(12): 201 doi: 10.1007/s11894-022-00856-3